Ticker	Volume	Price	Price Delta
DJIA	15,303.10	+8.60	0.06%
S&P 500	1,649.60	-0.91	-0.06%
Nasdaq	3,459.14	-0.27	-0.01%

Ticker

Volume

Price

Price Delta

DJIA

15,303.10

+8.60

0.06%

S&P 500

1,649.60

-0.91

-0.06%

Nasdaq

3,459.14

-0.27

-0.01%

Ticker	Volume	Price	Price Delta
STOXX 50	2,764.29	-12.49	-0.45%
FTSE 100	6,654.34	-42.45	-0.63%
DAX	8,305.32	-46.66	-0.56%

Ticker

Volume

Price

Price Delta

STOXX 50

2,764.29

-12.49

-0.45%

FTSE 100

6,654.34

-42.45

-0.63%

DAX

8,305.32

-46.66

-0.56%

Ticker	Volume	Price	Price Delta
Nikkei	14,612.50	+128.47	0.89%
Hang Seng	22,618.70	-51.01	-0.23%
S&P/ASX 200	4,983.50	-78.95	-1.56%

Ticker

Volume

Price

Price Delta

Nikkei

14,612.50

+128.47

0.89%

Hang Seng

22,618.70

-51.01

-0.23%

S&P/ASX 200

4,983.50

-78.95

-1.56%

Exchange: Frankfurt
Sector: Consumer, Non-cyclical
Industry: Healthcare-Products
Sub-Industry: Medical Products

Haemonetics Corp

+ Add to Watchlist

HAZ:GR

31.333 EUR 0.329 1.04%

Share this quote:

Post this quote on one of these sites:

Copy permanent URL

As of 09:37:10 ET on 05/24/2013.

Snapshot for Haemonetics Corp (HAZ)

Open:	31.770	Day's Range:	31.333 - 31.770	Volume:	0
Previous Close:	31.662	52wk Range:	27.211 - 33.181	1-Yr Rtn:	+13.39%

Stock Chart for HAZ

No chart data available.

HAZ:GR 31.770

31.662

Interactive HAZ Chart

…

Previous Close

Key Statistics for HAZ

Current P/E Ratio (ttm)	-
Estimated P/E(03/2014)	18.6025
Relative P/E vs. DAX	-
Earnings Per Share (USD) (ttm)	-
Est. EPS (USD) (03/2014)	2.1760
Est. PEG Ratio	1.4590
Market Cap (M EUR)	0.00
Shares Outstanding (M)	0.00
30 Day Average Volume	0
Price/Book (mrq)	-
Price/Sale (ttm)	-
Dividend Indicated Gross Yield	-%
Cash Dividend	-
Last Dividend
5 Year Dividend Growth	-
Next Earnings Announcement	08/01/2013

mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HAZ

Revenue
Net Income (M/USD)

Profit Margin (%)

Company Profile & Key Executives for HAZ

Haemonetics Corporation designs, manufactures, and markets automated blood processing systems. The Company's products are for use in surgical blood salvage, blood component collections, and plasma collections. Haemonetics markets its products worldwide, primarily outside the United States.

Richard J Meelia "Rich"Non Executive Chairman	Brian P ConcannonPresident/CEO
Michael Kelly "Mike"President:North America	Christopher J LindopVP:Business Development/CFO

More Company Profile & Key Executives for HAZ

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.